Impact of Antidiabetic Medications on Survival Outcomes in Patients with Cancer
Metformin use linked to lower death rates in cancer patients
A large-scale meta-analysis reveals significant differences in mortality risks between metformin, insulin, and SGLT2 inhibitors in cancer pa…
A large study of over one million patients suggests that the common diabetes drug metformin may help lower mortality rates for those with ca…
Thiazolidinediones increase bladder cancer risk while SGLT2 inhibitors show potential protective effects in Type 2 Diabetes
Diabetes medications show different links to bladder cancer risk
This meta-analysis of 85 studies evaluated the association between various antidiabetic medications and bladder cancer risk in patients with…
New data shows that while some diabetes medications may increase bladder cancer risk, others might offer a protective effect.
Thiazolidinediones show lower hepatocellular carcinoma risk than DPP-4 inhibitors, GLP-1RAs, insulin, and sulfonylureas in this network meta-analysis
New analysis links diabetes drugs to liver outcomes in millions of patients
This network meta-analysis evaluated major adverse liver outcomes among 7124845 adults with type 2 diabetes using glucose-lowering drug clas…
A massive analysis of millions of patients found some diabetes medications linked to lower risks of serious liver events compared to others.